# Phase 221 Summary

completed: 2026-04-26
requirements-completed: [RDG-05, RDG-06]
commit: 6e66eaf

## Changes

- Added a `Release readiness sequence` to `docs/releasing.md` covering Doctor, package validation, native validation, benchmark gates, consumer smoke, and issue-specific support artifacts.
- Added support-artifact routing guidance to `docs/alpha-feedback.md` for Doctor, MinimalSample, Demo, packaged consumer smoke, and SurfaceCharts support summaries.
- Extended `docs/videra-doctor.md` so Doctor references the actual scripts and source-controlled contracts it reports.
- Added repository guard tests for release readiness docs, support routing, and Doctor script/contract/artifact references.
- Closed the known `per-object`/`per-primitive` transparency wording drift across docs and `VideraBackendDiagnostics.CurrentTransparentFeatureStatus`.

## Notes

- Doctor remains repo-only and non-mutating.
- No release workflow, package publish, tag creation, feed push, or user configuration mutation was performed.
- The user-level `local-artifacts` NuGet source still points at a missing phase206 path; verification used `--ignore-failed-sources` where restore was required.
